{"abstract": "Eli Lilly agreed on Monday to pay $6.5 billion to acquire ImClone Systems, the biotechnology company that is controlled by Carl C. Icahn and whose stock was involved in the insider trading scandal that sent Martha Stewart to jail.", "web_url": "https://dealbook.nytimes.com/2008/10/07/eli-lillys-expensive-imclone-deal/", "snippet": "", "lead_paragraph": "Eli Lilly agreed on Monday to pay $6.5 billion to acquire ImClone Systems, the biotechnology company that is controlled by Carl C. Icahn and whose stock was involved in the insider trading scandal that sent Martha Stewart to jail.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Eli Lilly\u2019s Expensive ImClone Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-10-07T11:26:48+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/c3262780-3455-5c30-9189-d0d5e37fe6ca", "word_count": 947, "uri": "nyt://article/c3262780-3455-5c30-9189-d0d5e37fe6ca"}